In recent years, nanoplastic and microplastic particles (NMPs) have emerged as substantial threats to human health, particularly as endocrine disruptors. The endocrine system is especially vulnerable to these particles due to its intricate network of hormonal regulation, in which even minor disturbances can lead to widespread physiological effects. Studies have shown the pervasive presence of NMPs in human tissues, including blood, and their potential to impair metabolic and hormonal health.1 This growing body of evidence underscores the urgent need to better understand the mechanisms by which NMPs interfere with endocrine function and to address their effect on public health.
The Lancet Diabetes & Endocrinology published a clinical update in Research Highlights on 15 Apr 2026. The item focuses on Implications of microplastics as emerging endocrine disruptors. Open the detail page to review the full original feed content.